 Nichole Carlson
Concepts (546)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis, Pulmonary | 3 | 2025 | 83 | 1.500 |
Why?
| | Bayes Theorem | 6 | 2020 | 401 | 1.240 |
Why?
| | Luteinizing Hormone | 11 | 2020 | 185 | 1.070 |
Why?
| | Outpatients | 8 | 2025 | 394 | 1.030 |
Why?
| | Tomography, X-Ray Computed | 5 | 2025 | 2679 | 1.010 |
Why?
| | Models, Statistical | 6 | 2020 | 670 | 0.970 |
Why?
| | Sarcoidosis | 2 | 2025 | 159 | 0.950 |
Why?
| | Hydrocortisone | 6 | 2015 | 323 | 0.880 |
Why?
| | Hormones | 3 | 2017 | 142 | 0.820 |
Why?
| | Emphysema | 1 | 2023 | 109 | 0.780 |
Why?
| | Hypothalamo-Hypophyseal System | 7 | 2017 | 197 | 0.720 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 290 | 0.680 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 752 | 0.670 |
Why?
| | Diabetes Complications | 1 | 2022 | 226 | 0.660 |
Why?
| | Data Interpretation, Statistical | 3 | 2017 | 363 | 0.660 |
Why?
| | Radiography, Thoracic | 2 | 2024 | 168 | 0.640 |
Why?
| | Disease Susceptibility | 1 | 2021 | 345 | 0.610 |
Why?
| | Metadata | 1 | 2018 | 14 | 0.590 |
Why?
| | State Health Plans | 2 | 2008 | 30 | 0.570 |
Why?
| | Computer Simulation | 4 | 2017 | 979 | 0.570 |
Why?
| | Models, Biological | 3 | 2017 | 1773 | 0.540 |
Why?
| | Follicle Stimulating Hormone | 9 | 2023 | 244 | 0.540 |
Why?
| | Ovary | 3 | 2017 | 221 | 0.530 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2015 | 142 | 0.510 |
Why?
| | Genome | 1 | 2018 | 291 | 0.510 |
Why?
| | Reproduction | 1 | 2017 | 204 | 0.500 |
Why?
| | Alzheimer Disease | 5 | 2025 | 559 | 0.490 |
Why?
| | Child Health Services | 2 | 2008 | 185 | 0.480 |
Why?
| | Residence Characteristics | 6 | 2010 | 356 | 0.480 |
Why?
| | Humans | 97 | 2025 | 137294 | 0.470 |
Why?
| | Contraceptives, Oral, Combined | 7 | 2011 | 19 | 0.460 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 612 | 0.440 |
Why?
| | Biometry | 2 | 2017 | 70 | 0.440 |
Why?
| | Health Services for the Aged | 2 | 2019 | 80 | 0.440 |
Why?
| | Software | 2 | 2019 | 667 | 0.440 |
Why?
| | Brain Injuries | 5 | 2010 | 493 | 0.440 |
Why?
| | Female | 74 | 2025 | 73052 | 0.440 |
Why?
| | Obesity | 12 | 2023 | 2983 | 0.430 |
Why?
| | Computational Biology | 1 | 2018 | 646 | 0.430 |
Why?
| | Antiparkinson Agents | 3 | 2009 | 28 | 0.420 |
Why?
| | Adult | 53 | 2025 | 37724 | 0.410 |
Why?
| | Pulsatile Flow | 1 | 2013 | 60 | 0.410 |
Why?
| | Environment Design | 3 | 2010 | 27 | 0.410 |
Why?
| | Circadian Rhythm | 4 | 2013 | 468 | 0.410 |
Why?
| | Antibodies, Viral | 5 | 2024 | 624 | 0.400 |
Why?
| | Antibodies, Monoclonal | 6 | 2025 | 1431 | 0.400 |
Why?
| | Dehydroepiandrosterone | 1 | 2013 | 51 | 0.400 |
Why?
| | Aged | 29 | 2025 | 23851 | 0.400 |
Why?
| | Health Services Accessibility | 4 | 2010 | 982 | 0.390 |
Why?
| | Middle Aged | 39 | 2025 | 33310 | 0.380 |
Why?
| | Specimen Handling | 1 | 2013 | 181 | 0.360 |
Why?
| | Gonadotropins | 3 | 2023 | 40 | 0.360 |
Why?
| | Saliva | 1 | 2013 | 244 | 0.360 |
Why?
| | Male | 46 | 2025 | 67560 | 0.340 |
Why?
| | Walking | 4 | 2010 | 524 | 0.340 |
Why?
| | White Matter | 2 | 2023 | 145 | 0.330 |
Why?
| | Levodopa | 2 | 2007 | 31 | 0.330 |
Why?
| | Oregon | 8 | 2011 | 72 | 0.330 |
Why?
| | Hypogonadism | 2 | 2015 | 88 | 0.320 |
Why?
| | Lung | 5 | 2025 | 4067 | 0.320 |
Why?
| | Antibodies, Neutralizing | 4 | 2025 | 285 | 0.320 |
Why?
| | Hospitalization | 8 | 2024 | 2214 | 0.310 |
Why?
| | Endocrine System | 1 | 2009 | 20 | 0.310 |
Why?
| | Parkinson Disease | 4 | 2009 | 491 | 0.310 |
Why?
| | Activities of Daily Living | 3 | 2010 | 415 | 0.310 |
Why?
| | Statistics as Topic | 3 | 2025 | 313 | 0.310 |
Why?
| | Testosterone | 2 | 2010 | 401 | 0.300 |
Why?
| | Technology | 1 | 2009 | 96 | 0.290 |
Why?
| | Prenatal Care | 1 | 2010 | 288 | 0.290 |
Why?
| | Estradiol | 6 | 2023 | 518 | 0.280 |
Why?
| | Cerebral Ventricles | 1 | 2007 | 52 | 0.280 |
Why?
| | Levonorgestrel | 4 | 2011 | 38 | 0.280 |
Why?
| | Metrorrhagia | 3 | 2011 | 4 | 0.270 |
Why?
| | Health Behavior | 3 | 2010 | 757 | 0.270 |
Why?
| | Cognition Disorders | 3 | 2008 | 515 | 0.270 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2516 | 0.270 |
Why?
| | Aged, 80 and over | 12 | 2025 | 7607 | 0.270 |
Why?
| | Perception | 2 | 2007 | 361 | 0.270 |
Why?
| | Methylphenidate | 1 | 2007 | 38 | 0.260 |
Why?
| | Young Adult | 15 | 2024 | 13163 | 0.260 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2007 | 59 | 0.260 |
Why?
| | Smoking Cessation | 1 | 2010 | 446 | 0.250 |
Why?
| | Time Factors | 13 | 2017 | 6818 | 0.240 |
Why?
| | Longitudinal Studies | 10 | 2020 | 2850 | 0.230 |
Why?
| | Poverty | 2 | 2010 | 521 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3710 | 0.230 |
Why?
| | Cluster Analysis | 2 | 2023 | 497 | 0.230 |
Why?
| | Gliosis | 2 | 2023 | 28 | 0.230 |
Why?
| | Health Care Rationing | 1 | 2024 | 59 | 0.220 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 66 | 0.220 |
Why?
| | Brain Ischemia | 2 | 2017 | 343 | 0.220 |
Why?
| | Healthcare Disparities | 1 | 2010 | 652 | 0.210 |
Why?
| | Denmark | 2 | 2021 | 46 | 0.210 |
Why?
| | Alanine | 1 | 2024 | 151 | 0.210 |
Why?
| | Medicaid | 1 | 2008 | 434 | 0.210 |
Why?
| | Neurology | 1 | 2025 | 114 | 0.210 |
Why?
| | Spirometry | 2 | 2024 | 281 | 0.200 |
Why?
| | Retrospective Studies | 13 | 2024 | 15639 | 0.200 |
Why?
| | Risk Factors | 10 | 2022 | 10368 | 0.200 |
Why?
| | Oocytes | 2 | 2020 | 180 | 0.200 |
Why?
| | Body Mass Index | 6 | 2019 | 2373 | 0.190 |
Why?
| | Neuropsychological Tests | 3 | 2025 | 1055 | 0.190 |
Why?
| | Socioeconomic Factors | 5 | 2010 | 1286 | 0.190 |
Why?
| | Benchmarking | 1 | 2023 | 184 | 0.190 |
Why?
| | Markov Chains | 3 | 2017 | 123 | 0.190 |
Why?
| | Monte Carlo Method | 3 | 2017 | 147 | 0.190 |
Why?
| | Aging | 4 | 2008 | 1864 | 0.180 |
Why?
| | Respiratory Function Tests | 2 | 2024 | 596 | 0.180 |
Why?
| | Cross-Sectional Studies | 12 | 2018 | 5436 | 0.180 |
Why?
| | Prospective Studies | 9 | 2023 | 7595 | 0.180 |
Why?
| | Antiviral Agents | 2 | 2024 | 741 | 0.180 |
Why?
| | Disability Evaluation | 4 | 2018 | 290 | 0.180 |
Why?
| | Cohort Studies | 7 | 2025 | 5726 | 0.180 |
Why?
| | Doxycycline | 2 | 2011 | 62 | 0.170 |
Why?
| | Ethinyl Estradiol | 2 | 2011 | 16 | 0.170 |
Why?
| | Oocyte Donation | 1 | 2020 | 4 | 0.170 |
Why?
| | Weight Gain | 2 | 2022 | 519 | 0.170 |
Why?
| | Healthy Aging | 1 | 2021 | 35 | 0.170 |
Why?
| | Preimplantation Diagnosis | 1 | 2020 | 7 | 0.170 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2021 | 100 | 0.170 |
Why?
| | Prescription Drugs | 1 | 2022 | 109 | 0.170 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 99 | 0.170 |
Why?
| | Memory, Episodic | 1 | 2021 | 52 | 0.170 |
Why?
| | Myocardial Infarction | 2 | 2017 | 1045 | 0.170 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 37 | 0.170 |
Why?
| | Cytomegalovirus Infections | 1 | 2022 | 191 | 0.160 |
Why?
| | Cross-Over Studies | 6 | 2025 | 562 | 0.160 |
Why?
| | Apomorphine | 3 | 2009 | 7 | 0.160 |
Why?
| | Proton Pump Inhibitors | 2 | 2017 | 109 | 0.160 |
Why?
| | Aromatase Inhibitors | 1 | 2020 | 53 | 0.160 |
Why?
| | Fractals | 1 | 2019 | 8 | 0.160 |
Why?
| | Menstruation | 2 | 1991 | 43 | 0.160 |
Why?
| | Comprehensive Health Care | 1 | 2019 | 23 | 0.160 |
Why?
| | Radial Nerve | 1 | 1999 | 9 | 0.160 |
Why?
| | Nerve Compression Syndromes | 1 | 1999 | 21 | 0.160 |
Why?
| | Severity of Illness Index | 7 | 2024 | 2836 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3283 | 0.160 |
Why?
| | Internet | 2 | 2018 | 651 | 0.160 |
Why?
| | Human Growth Hormone | 2 | 2014 | 45 | 0.160 |
Why?
| | Machine Learning | 1 | 2024 | 491 | 0.150 |
Why?
| | Health Status | 3 | 2010 | 789 | 0.150 |
Why?
| | Astrocytes | 1 | 2021 | 210 | 0.150 |
Why?
| | Quality of Life | 5 | 2018 | 2885 | 0.150 |
Why?
| | Proportional Hazards Models | 3 | 2017 | 1260 | 0.150 |
Why?
| | Biomedical Research | 1 | 2025 | 693 | 0.150 |
Why?
| | Vital Capacity | 1 | 2019 | 309 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2018 | 119 | 0.150 |
Why?
| | Hip Fractures | 1 | 2019 | 99 | 0.140 |
Why?
| | Bibliometrics | 1 | 2018 | 63 | 0.140 |
Why?
| | Sheep, Domestic | 1 | 2017 | 34 | 0.140 |
Why?
| | Regression Analysis | 2 | 2019 | 1028 | 0.140 |
Why?
| | Anxiety | 1 | 2025 | 1036 | 0.140 |
Why?
| | Case-Control Studies | 5 | 2021 | 3546 | 0.140 |
Why?
| | Contraception | 2 | 1991 | 162 | 0.140 |
Why?
| | Eligibility Determination | 2 | 2008 | 65 | 0.140 |
Why?
| | Reproductive Physiological Phenomena | 1 | 2017 | 1 | 0.140 |
Why?
| | Rhinitis | 2 | 2010 | 158 | 0.140 |
Why?
| | Algorithms | 3 | 2017 | 1692 | 0.140 |
Why?
| | Adolescent | 14 | 2024 | 21499 | 0.140 |
Why?
| | Medically Uninsured | 2 | 2008 | 129 | 0.130 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 745 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 108 | 0.130 |
Why?
| | Premature Birth | 1 | 2020 | 331 | 0.130 |
Why?
| | Lactation | 1 | 2018 | 181 | 0.130 |
Why?
| | Psychomotor Performance | 3 | 2009 | 313 | 0.130 |
Why?
| | Family Planning Services | 2 | 2008 | 92 | 0.130 |
Why?
| | Affect | 3 | 2008 | 293 | 0.130 |
Why?
| | Hypothyroidism | 2 | 2007 | 72 | 0.130 |
Why?
| | Sinusitis | 2 | 2010 | 221 | 0.130 |
Why?
| | Double-Blind Method | 7 | 2011 | 1985 | 0.130 |
Why?
| | Pregnancy | 8 | 2023 | 6743 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 412 | 0.130 |
Why?
| | Endoscopy | 2 | 2010 | 318 | 0.130 |
Why?
| | Low Back Pain | 1 | 2018 | 104 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 176 | 0.130 |
Why?
| | Dietary Fats | 1 | 2018 | 304 | 0.130 |
Why?
| | Models, Animal | 1 | 2017 | 384 | 0.120 |
Why?
| | Immunologic Memory | 1 | 2018 | 370 | 0.120 |
Why?
| | Brain | 6 | 2023 | 2675 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2021 | 368 | 0.120 |
Why?
| | Personnel Selection | 1 | 2016 | 78 | 0.120 |
Why?
| | Recovery of Function | 2 | 2010 | 657 | 0.120 |
Why?
| | Otolaryngology | 1 | 2016 | 96 | 0.120 |
Why?
| | Patient Dropouts | 1 | 2015 | 67 | 0.110 |
Why?
| | Pulmonary Embolism | 1 | 2017 | 226 | 0.110 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2014 | 11 | 0.110 |
Why?
| | Acromegaly | 1 | 2014 | 14 | 0.110 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2015 | 130 | 0.110 |
Why?
| | Pituitary-Adrenal System | 3 | 2013 | 162 | 0.110 |
Why?
| | Menstrual Cycle | 3 | 2011 | 132 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 139 | 0.110 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2020 | 212 | 0.110 |
Why?
| | Breast Feeding | 1 | 2018 | 439 | 0.110 |
Why?
| | Analysis of Variance | 5 | 2009 | 1318 | 0.110 |
Why?
| | Health Care Costs | 1 | 2017 | 387 | 0.110 |
Why?
| | Dementia | 2 | 2008 | 256 | 0.110 |
Why?
| | Drug Administration Schedule | 4 | 2010 | 786 | 0.110 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 222 | 0.110 |
Why?
| | Antibody Formation | 2 | 2022 | 298 | 0.110 |
Why?
| | Biomarkers | 4 | 2021 | 4164 | 0.100 |
Why?
| | Secretory Rate | 1 | 2013 | 16 | 0.100 |
Why?
| | Health Policy | 2 | 2024 | 389 | 0.100 |
Why?
| | Electronics | 1 | 2013 | 75 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1167 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2010 | 770 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 333 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 219 | 0.100 |
Why?
| | Neurosurgical Procedures | 1 | 2014 | 197 | 0.100 |
Why?
| | Medical Records | 1 | 2013 | 174 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1623 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 389 | 0.090 |
Why?
| | Education, Medical, Graduate | 1 | 2016 | 482 | 0.090 |
Why?
| | Wakefulness | 1 | 2013 | 125 | 0.090 |
Why?
| | Adenoma | 1 | 2014 | 231 | 0.090 |
Why?
| | Age Factors | 8 | 2018 | 3297 | 0.090 |
Why?
| | Treatment Outcome | 8 | 2024 | 10800 | 0.090 |
Why?
| | Urban Health | 2 | 2009 | 92 | 0.090 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 540 | 0.090 |
Why?
| | Memory | 3 | 2008 | 255 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2017 | 5125 | 0.090 |
Why?
| | Progestins | 1 | 2011 | 78 | 0.090 |
Why?
| | Cognition | 3 | 2008 | 1169 | 0.090 |
Why?
| | Equipment Design | 1 | 2013 | 522 | 0.090 |
Why?
| | Dietary Supplements | 1 | 2015 | 562 | 0.090 |
Why?
| | Amenorrhea | 1 | 2011 | 27 | 0.090 |
Why?
| | Dopamine Agonists | 2 | 2008 | 40 | 0.090 |
Why?
| | Insulin | 1 | 2022 | 2406 | 0.090 |
Why?
| | Birth Certificates | 1 | 2010 | 10 | 0.090 |
Why?
| | Contraceptives, Oral, Hormonal | 2 | 2007 | 33 | 0.090 |
Why?
| | Estrone | 1 | 2010 | 37 | 0.090 |
Why?
| | Risk Assessment | 2 | 2017 | 3439 | 0.090 |
Why?
| | Birth Rate | 2 | 2020 | 30 | 0.090 |
Why?
| | Dihydrotestosterone | 1 | 2010 | 44 | 0.090 |
Why?
| | Cytokines | 2 | 2015 | 2090 | 0.090 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2010 | 15 | 0.090 |
Why?
| | Automobile Driving | 2 | 2010 | 148 | 0.080 |
Why?
| | Live Birth | 2 | 2020 | 65 | 0.080 |
Why?
| | Pregnancy Rate | 2 | 2020 | 65 | 0.080 |
Why?
| | Geographic Information Systems | 2 | 2010 | 44 | 0.080 |
Why?
| | Diet | 1 | 2018 | 1275 | 0.080 |
Why?
| | Fertilization in Vitro | 2 | 2020 | 83 | 0.080 |
Why?
| | Thyroxine | 2 | 2007 | 62 | 0.080 |
Why?
| | Cities | 1 | 2010 | 132 | 0.080 |
Why?
| | Registries | 1 | 2017 | 2016 | 0.080 |
Why?
| | Abortion, Induced | 2 | 2008 | 103 | 0.080 |
Why?
| | United States | 6 | 2020 | 14742 | 0.080 |
Why?
| | Personality | 1 | 2011 | 132 | 0.080 |
Why?
| | Sex Factors | 5 | 2018 | 2073 | 0.080 |
Why?
| | Electrical Equipment and Supplies | 1 | 2009 | 9 | 0.080 |
Why?
| | Rehabilitation Centers | 1 | 2009 | 39 | 0.080 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 73 | 0.080 |
Why?
| | Stroke | 1 | 2017 | 1134 | 0.080 |
Why?
| | Telecommunications | 1 | 2009 | 21 | 0.080 |
Why?
| | Independent Living | 1 | 2010 | 105 | 0.070 |
Why?
| | Progesterone | 3 | 2015 | 254 | 0.070 |
Why?
| | Rural Health | 1 | 2009 | 79 | 0.070 |
Why?
| | Postmenopause | 1 | 2010 | 365 | 0.070 |
Why?
| | Drug Interactions | 2 | 2007 | 406 | 0.070 |
Why?
| | Mortality | 1 | 2011 | 361 | 0.070 |
Why?
| | Thyrotoxicosis | 1 | 2008 | 9 | 0.070 |
Why?
| | Monitoring, Ambulatory | 1 | 2009 | 87 | 0.070 |
Why?
| | Logistic Models | 2 | 2010 | 2071 | 0.070 |
Why?
| | Foot | 1 | 2009 | 97 | 0.070 |
Why?
| | Ointments | 1 | 2007 | 25 | 0.070 |
Why?
| | Povidone-Iodine | 1 | 2007 | 11 | 0.070 |
Why?
| | Vaccinia | 1 | 2007 | 21 | 0.070 |
Why?
| | Smallpox Vaccine | 1 | 2007 | 23 | 0.070 |
Why?
| | Exercise | 3 | 2010 | 2045 | 0.070 |
Why?
| | Life Change Events | 1 | 2009 | 151 | 0.070 |
Why?
| | Vaccinia virus | 1 | 2007 | 43 | 0.070 |
Why?
| | Child, Preschool | 4 | 2018 | 11080 | 0.070 |
Why?
| | Pregnancy, Unplanned | 1 | 2008 | 48 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 2 | 2020 | 268 | 0.070 |
Why?
| | Parkinsonian Disorders | 1 | 2007 | 35 | 0.070 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2007 | 12 | 0.070 |
Why?
| | Counseling | 1 | 2010 | 393 | 0.070 |
Why?
| | Disease Progression | 3 | 2015 | 2752 | 0.070 |
Why?
| | Atrophy | 1 | 2007 | 184 | 0.070 |
Why?
| | Population Surveillance | 1 | 2010 | 473 | 0.070 |
Why?
| | Time Perception | 1 | 2007 | 28 | 0.070 |
Why?
| | Awareness | 1 | 2007 | 105 | 0.070 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 129 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2007 | 146 | 0.070 |
Why?
| | Antigens, Viral | 1 | 2007 | 181 | 0.070 |
Why?
| | Movement | 1 | 2009 | 272 | 0.070 |
Why?
| | Albumins | 1 | 2007 | 113 | 0.070 |
Why?
| | Tremor | 1 | 2007 | 65 | 0.060 |
Why?
| | Wounds, Gunshot | 1 | 2009 | 220 | 0.060 |
Why?
| | Internship and Residency | 1 | 2016 | 1137 | 0.060 |
Why?
| | Suicide, Attempted | 1 | 2009 | 373 | 0.060 |
Why?
| | Blood-Brain Barrier | 1 | 2007 | 140 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 586 | 0.060 |
Why?
| | Infant | 3 | 2010 | 9451 | 0.060 |
Why?
| | Paroxetine | 1 | 2005 | 11 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 2054 | 0.060 |
Why?
| | Treatment Failure | 2 | 2022 | 354 | 0.060 |
Why?
| | Animals | 7 | 2023 | 36862 | 0.060 |
Why?
| | Attitude to Health | 1 | 2008 | 440 | 0.060 |
Why?
| | Neurologic Examination | 2 | 2008 | 113 | 0.060 |
Why?
| | Administration, Oral | 1 | 2007 | 812 | 0.060 |
Why?
| | Health Promotion | 1 | 2010 | 737 | 0.060 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2024 | 75 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1946 | 0.050 |
Why?
| | Video Recording | 1 | 2025 | 181 | 0.050 |
Why?
| | Sexual Behavior | 1 | 2008 | 486 | 0.050 |
Why?
| | Patient Compliance | 1 | 2008 | 577 | 0.050 |
Why?
| | Likelihood Functions | 2 | 2017 | 144 | 0.050 |
Why?
| | Electronic Health Records | 2 | 2024 | 1045 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 12 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 208 | 0.050 |
Why?
| | Child | 5 | 2018 | 21999 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4527 | 0.050 |
Why?
| | Family | 1 | 2008 | 666 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 48 | 0.050 |
Why?
| | Linear Models | 2 | 2020 | 846 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 79 | 0.050 |
Why?
| | Physical Fitness | 1 | 2004 | 209 | 0.050 |
Why?
| | Emotions | 1 | 2007 | 547 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 719 | 0.050 |
Why?
| | Temporomandibular Joint Dysfunction Syndrome | 1 | 2002 | 2 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 73 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2007 | 765 | 0.050 |
Why?
| | Vaccines | 1 | 2007 | 406 | 0.050 |
Why?
| | Facial Pain | 1 | 2002 | 12 | 0.050 |
Why?
| | Urban Population | 1 | 2025 | 475 | 0.050 |
Why?
| | Physical Examination | 2 | 2018 | 243 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 1302 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2007 | 846 | 0.050 |
Why?
| | Acids | 1 | 2002 | 18 | 0.050 |
Why?
| | Administration, Cutaneous | 2 | 2015 | 128 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 153 | 0.050 |
Why?
| | Faculty, Medical | 1 | 2025 | 282 | 0.050 |
Why?
| | Odds Ratio | 3 | 2010 | 1067 | 0.050 |
Why?
| | Ovarian Follicle | 1 | 2002 | 71 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2008 | 3568 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1805 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 263 | 0.040 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 167 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2007 | 808 | 0.040 |
Why?
| | Rheumatoid Factor | 1 | 2022 | 175 | 0.040 |
Why?
| | Puberty | 1 | 2002 | 147 | 0.040 |
Why?
| | Leadership | 1 | 2025 | 382 | 0.040 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2022 | 115 | 0.040 |
Why?
| | Oocyte Retrieval | 1 | 2020 | 12 | 0.040 |
Why?
| | Pregnancy, Multiple | 1 | 2020 | 17 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2022 | 210 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 288 | 0.040 |
Why?
| | Leptin | 1 | 2002 | 236 | 0.040 |
Why?
| | Blastocyst | 1 | 2020 | 48 | 0.040 |
Why?
| | Embryo Transfer | 1 | 2020 | 32 | 0.040 |
Why?
| | Fasting | 1 | 2002 | 280 | 0.040 |
Why?
| | Breast Neoplasms | 2 | 2011 | 2243 | 0.040 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 5769 | 0.040 |
Why?
| | Prostaglandins | 1 | 2000 | 97 | 0.040 |
Why?
| | Radionuclide Imaging | 1 | 2019 | 118 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2009 | 2052 | 0.040 |
Why?
| | Vaccination | 2 | 2024 | 1379 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 220 | 0.040 |
Why?
| | Oligodendroglia | 1 | 2001 | 178 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1327 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 1999 | 102 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1408 | 0.040 |
Why?
| | Receptors, Nicotinic | 1 | 2001 | 335 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 2018 | 89 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2032 | 0.040 |
Why?
| | Controlled Before-After Studies | 1 | 2017 | 14 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2022 | 886 | 0.030 |
Why?
| | Depressive Disorder, Major | 1 | 2001 | 362 | 0.030 |
Why?
| | Milk | 1 | 2018 | 124 | 0.030 |
Why?
| | Depressive Disorder | 1 | 2000 | 380 | 0.030 |
Why?
| | Confidence Intervals | 2 | 2008 | 330 | 0.030 |
Why?
| | Protons | 1 | 2017 | 90 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 454 | 0.030 |
Why?
| | Biostatistics | 1 | 2017 | 18 | 0.030 |
Why?
| | Viruses | 1 | 2018 | 113 | 0.030 |
Why?
| | Psychological Tests | 1 | 2018 | 141 | 0.030 |
Why?
| | Electromyography | 1 | 1999 | 401 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 68 | 0.030 |
Why?
| | Incidence | 2 | 2017 | 2808 | 0.030 |
Why?
| | Thyrotropin | 2 | 2007 | 114 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 247 | 0.030 |
Why?
| | Stem Cells | 1 | 2001 | 593 | 0.030 |
Why?
| | Drug Combinations | 2 | 2011 | 344 | 0.030 |
Why?
| | Health Surveys | 2 | 2009 | 517 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1321 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2000 | 886 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 851 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 854 | 0.030 |
Why?
| | Neoplasms | 1 | 2011 | 2661 | 0.030 |
Why?
| | Escherichia coli | 1 | 2000 | 814 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 61 | 0.030 |
Why?
| | Fatty Liver | 1 | 2018 | 243 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 209 | 0.030 |
Why?
| | Systole | 1 | 2015 | 191 | 0.030 |
Why?
| | Drug Users | 1 | 2015 | 39 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1484 | 0.030 |
Why?
| | Electric Countershock | 1 | 2015 | 107 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 254 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1242 | 0.030 |
Why?
| | Risk | 1 | 2017 | 908 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2015 | 533 | 0.030 |
Why?
| | Phospholipids | 1 | 2015 | 222 | 0.030 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 185 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 114 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 994 | 0.030 |
Why?
| | Psychometrics | 1 | 2018 | 723 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2018 | 630 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 687 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 372 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3202 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4284 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 892 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5753 | 0.020 |
Why?
| | Follicular Phase | 2 | 2004 | 39 | 0.020 |
Why?
| | Estrogens | 1 | 2015 | 368 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 444 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2018 | 648 | 0.020 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 315 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 753 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1521 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 607 | 0.020 |
Why?
| | Periodicity | 2 | 2001 | 59 | 0.020 |
Why?
| | Prognosis | 1 | 1999 | 4026 | 0.020 |
Why?
| | Abbreviated Injury Scale | 1 | 2010 | 22 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2010 | 106 | 0.020 |
Why?
| | Nasal Polyps | 1 | 2010 | 59 | 0.020 |
Why?
| | Life Expectancy | 1 | 2010 | 68 | 0.020 |
Why?
| | Amides | 1 | 2010 | 93 | 0.020 |
Why?
| | Heart-Assist Devices | 1 | 2015 | 552 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2010 | 182 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6054 | 0.020 |
Why?
| | Obstetrics | 1 | 2011 | 163 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 818 | 0.020 |
Why?
| | Income | 1 | 2010 | 203 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2015 | 747 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1095 | 0.020 |
Why?
| | Norgestrel | 1 | 1988 | 2 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 1988 | 16 | 0.020 |
Why?
| | Medroxyprogesterone | 1 | 1988 | 11 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 432 | 0.020 |
Why?
| | Benzodioxoles | 1 | 2010 | 115 | 0.020 |
Why?
| | Family Characteristics | 1 | 2010 | 189 | 0.020 |
Why?
| | Medroxyprogesterone Acetate | 1 | 1988 | 36 | 0.020 |
Why?
| | Gynecology | 1 | 2011 | 176 | 0.020 |
Why?
| | Poverty Areas | 1 | 2008 | 39 | 0.020 |
Why?
| | Thyroid Function Tests | 1 | 2008 | 14 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2009 | 286 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2008 | 59 | 0.020 |
Why?
| | Receptors, Dopamine | 1 | 2008 | 20 | 0.020 |
Why?
| | Sheep | 2 | 2002 | 855 | 0.020 |
Why?
| | Smallpox | 1 | 2007 | 8 | 0.020 |
Why?
| | Parity | 1 | 1988 | 126 | 0.020 |
Why?
| | Galvanic Skin Response | 1 | 2007 | 26 | 0.020 |
Why?
| | Employment | 1 | 2010 | 178 | 0.020 |
Why?
| | Diphtheria | 1 | 2007 | 20 | 0.020 |
Why?
| | Tetanus | 1 | 2007 | 25 | 0.020 |
Why?
| | Virus Shedding | 1 | 2007 | 48 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2010 | 210 | 0.020 |
Why?
| | Commerce | 1 | 2008 | 79 | 0.020 |
Why?
| | Half-Life | 1 | 2007 | 165 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 90 | 0.020 |
Why?
| | Cause of Death | 1 | 2010 | 429 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2007 | 150 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 532 | 0.020 |
Why?
| | Plasma Cells | 1 | 2007 | 71 | 0.020 |
Why?
| | Seroepidemiologic Studies | 1 | 2007 | 164 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 484 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2007 | 47 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2007 | 43 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 508 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2007 | 83 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2007 | 241 | 0.020 |
Why?
| | Research | 1 | 2010 | 449 | 0.020 |
Why?
| | Thyroid Hormones | 1 | 2007 | 61 | 0.020 |
Why?
| | Family Practice | 1 | 2011 | 462 | 0.020 |
Why?
| | Thyroid Gland | 1 | 2007 | 94 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2007 | 96 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 169 | 0.020 |
Why?
| | Safety | 1 | 2008 | 343 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 519 | 0.020 |
Why?
| | Motor Skills | 1 | 2007 | 98 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2010 | 657 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2008 | 548 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 323 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 201 | 0.020 |
Why?
| | Dopamine Agents | 1 | 2005 | 19 | 0.010 |
Why?
| | Virus Diseases | 1 | 2007 | 214 | 0.010 |
Why?
| | Vestibular Diseases | 1 | 2005 | 25 | 0.010 |
Why?
| | Down-Regulation | 1 | 2007 | 658 | 0.010 |
Why?
| | Comorbidity | 1 | 2010 | 1624 | 0.010 |
Why?
| | Gait Disorders, Neurologic | 1 | 2005 | 46 | 0.010 |
Why?
| | Dizziness | 1 | 2005 | 83 | 0.010 |
Why?
| | Self Efficacy | 1 | 2008 | 395 | 0.010 |
Why?
| | Inpatients | 1 | 2009 | 503 | 0.010 |
Why?
| | Memory, Short-Term | 1 | 2007 | 255 | 0.010 |
Why?
| | Presynaptic Terminals | 1 | 2005 | 88 | 0.010 |
Why?
| | Diet Records | 1 | 2004 | 83 | 0.010 |
Why?
| | Length of Stay | 1 | 2009 | 1218 | 0.010 |
Why?
| | Chronic Disease | 1 | 2010 | 1788 | 0.010 |
Why?
| | Menarche | 1 | 2004 | 60 | 0.010 |
Why?
| | Research Design | 1 | 2010 | 1128 | 0.010 |
Why?
| | Overweight | 1 | 2008 | 557 | 0.010 |
Why?
| | Serotonin | 1 | 2005 | 323 | 0.010 |
Why?
| | Skin | 1 | 2007 | 751 | 0.010 |
Why?
| | Accidental Falls | 1 | 2005 | 194 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2011 | 1101 | 0.010 |
Why?
| | Adrenal Cortex | 1 | 2002 | 29 | 0.010 |
Why?
| | Follicular Fluid | 1 | 2002 | 5 | 0.010 |
Why?
| | Dopamine | 1 | 2005 | 303 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1464 | 0.010 |
Why?
| | Neuraminidase | 1 | 2002 | 25 | 0.010 |
Why?
| | Caregivers | 1 | 2010 | 876 | 0.010 |
Why?
| | Contraceptives, Oral | 1 | 2002 | 43 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2002 | 171 | 0.010 |
Why?
| | Heart Failure | 1 | 2015 | 2234 | 0.010 |
Why?
| | Dipeptides | 1 | 2002 | 50 | 0.010 |
Why?
| | Thinness | 1 | 2002 | 91 | 0.010 |
Why?
| | Dihydro-beta-Erythroidine | 1 | 2001 | 6 | 0.010 |
Why?
| | Postprandial Period | 1 | 2002 | 107 | 0.010 |
Why?
| | Fura-2 | 1 | 2001 | 12 | 0.010 |
Why?
| | Nifedipine | 1 | 2001 | 29 | 0.010 |
Why?
| | Nicotinic Antagonists | 1 | 2001 | 34 | 0.010 |
Why?
| | Pituitary Gland | 1 | 2002 | 149 | 0.010 |
Why?
| | Energy Intake | 1 | 2004 | 484 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2004 | 696 | 0.010 |
Why?
| | Luteal Phase | 1 | 2000 | 45 | 0.010 |
Why?
| | Area Under Curve | 1 | 2001 | 315 | 0.010 |
Why?
| | HIV Infections | 1 | 2015 | 2820 | 0.010 |
Why?
| | Prostaglandin Antagonists | 1 | 2000 | 2 | 0.010 |
Why?
| | Flurbiprofen | 1 | 2000 | 3 | 0.010 |
Why?
| | Depression, Chemical | 1 | 2000 | 23 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2002 | 403 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2001 | 167 | 0.010 |
Why?
| | Pain Measurement | 1 | 2002 | 524 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 318 | 0.010 |
Why?
| | Fever | 1 | 2000 | 308 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2419 | 0.010 |
Why?
| | Hypertension | 1 | 2007 | 1285 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1501 | 0.010 |
Why?
| | Sleep | 1 | 2002 | 755 | 0.010 |
Why?
| | Calcium | 1 | 2001 | 1198 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4197 | 0.010 |
Why?
| | Rats | 1 | 2001 | 5639 | 0.010 |
Why?
| | Neurons | 1 | 2001 | 1588 | 0.010 |
Why?
| | Mice | 1 | 2007 | 17774 | 0.010 |
Why?
|
|
Carlson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|